Daniel J. Sargent

发表

Comparative assessment of trial-level surrogacy measures for candidate time-to-event surrogate endpoints in clinical trials

Qian Shi, Tomasz Burzykowski, Brian M. Bot, 2011, Comput. Stat. Data Anal..

The Direct Assignment Option as a Modular Design Component: An Example for the Setting of Two Predefined Subgroups

Xin Lu, Sumithra J. Mandrekar, Daniel J. Sargent, 2015, Comput. Math. Methods Medicine.

Smoothing Balanced Single-Error-Term Analysis of Variance

Bradley P. Carlin, Yue Cui, James S. Hodges, 2007, Technometrics.

Structured Markov Chain Monte Carlo

Bradley P. Carlin, James S. Hodges, Daniel J. Sargent, 2000 .

Center-within-trial versus trial-level evaluation of surrogate endpoints

Yuan Xue, Qian Shi, Junlong Li, 2014, Comput. Stat. Data Anal..

Robust Bayesian design and analysis of clinical trials via prior partitioning

Bradley P. Carlin, Daniel J. Sargent, B. Carlin, 1996 .

Biostatistics and bioinformatics

Daniel J. Sargent, Qian D Shi, D. Sargent, 2012 .

A new strategy for speeding Markov chain Monte Carlo algorithms

Antonietta Mira, Daniel J. Sargent, 2003 .

Heterogeneity in early lesion changes on treatment as a marker of poor prognosis in patients (pts) with metastatic colorectal cancer (mCRC) treated with first line systemic chemotherapy ± biologic: Findings from 9,092 pts in the ARCAD database.

Qian Shi, Daniel J. Sargent, Fang-Shu Ou, 2017 .

Role of sensitivity analyses in assessing progression-free survival in late-stage oncology trials.

Daniel J. Sargent, R. Gray, D. Sargent, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Drug rechallenge and treatment beyond progression—implications for drug resistance

Daniel J. Sargent, Robert S. Kerbel, D. Sargent, 2013, Nature Reviews Clinical Oncology.

Meta-analysis of Individual-patient Survival Data Using Random-effect Models

Daniel J. Sargent, Valter Torri, Benny Chung-ying Zee, 2000 .

Phase III CORRECT trial of regorafenib in metastatic colorectal cancer (mCRC)

Daniel J. Sargent, Olivier Bouché, Alberto Sobrero, 2012 .

Comparison of Continuous versus Categorical Tumor Measurement–Based Metrics to Predict Overall Survival in Cancer Treatment Trials

Sumithra J. Mandrekar, Henry C. Pitot, Daniel J. Sargent, 2011, Clinical Cancer Research.

Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741.

Henry C. Pitot, Daniel J. Sargent, Stephen K. Williamson, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.